Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1968 2
1969 3
1970 2
1971 1
1972 4
1973 3
1974 4
1975 7
1976 3
1977 1
1978 1
1979 6
1980 3
1981 6
1982 3
1983 6
1984 10
1985 11
1986 1
1987 4
1988 11
1989 5
1990 15
1991 17
1992 13
1993 14
1994 18
1995 13
1996 10
1997 8
1998 12
1999 20
2000 16
2001 29
2002 21
2003 17
2004 15
2005 20
2006 35
2007 28
2008 31
2009 29
2010 41
2011 36
2012 64
2013 67
2014 71
2015 71
2016 51
2017 72
2018 73
2019 70
2020 81
2021 93
2022 62
2023 55
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,246 results

Results by year

Filters applied: . Clear all
Page 1
Personalized Management of Pheochromocytoma and Paraganglioma.
Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K. Nölting S, et al. Endocr Rev. 2022 Mar 9;43(2):199-239. doi: 10.1210/endrev/bnab019. Endocr Rev. 2022. PMID: 34147030 Free PMC article. Review.
In contrast, kinase signaling-related cluster 2 tumors are characterized by an adrenergic phenotype and episodic symptoms, with generally a less aggressive course. The clinical correlates of patients with Wnt signaling-related cluster 3 tumors are currently poorly describe …
In contrast, kinase signaling-related cluster 2 tumors are characterized by an adrenergic phenotype and episodic symptoms, with generally a …
Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Mete O, et al. Endocr Pathol. 2022 Mar;33(1):90-114. doi: 10.1007/s12022-022-09704-6. Epub 2022 Mar 13. Endocr Pathol. 2022. PMID: 35285002 Review.
Since the 4th edition of the WHO, paragangliomas have no longer been classified as benign and malignant, as any lesion can have metastatic potential and there are no clear-cut features that can predict metastatic behavior. Moreover, some tumors are lethal without metastati …
Since the 4th edition of the WHO, paragangliomas have no longer been classified as benign and malignant, as any lesion can have metastatic p …
Metastatic Pheochromocytomas and Abdominal Paragangliomas.
Granberg D, Juhlin CC, Falhammar H. Granberg D, et al. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e1937-e1952. doi: 10.1210/clinem/dgaa982. J Clin Endocrinol Metab. 2021. PMID: 33462603 Free PMC article. Review.
DATA SYNTHESIS: To pinpoint metastatic potential in PPGLs is difficult, but nevertheless crucial for the individual patient to receive tailor-made follow-up and adjuvant treatment following primary surgery. A combination of histological workup and molecular predictive mark …
DATA SYNTHESIS: To pinpoint metastatic potential in PPGLs is difficult, but nevertheless crucial for the individual patient to receive tailo …
Vagal paragangliomas.
Mottie L, Meulemans J, Vander Poorten V. Mottie L, et al. Curr Opin Otolaryngol Head Neck Surg. 2023 Apr 1;31(2):146-154. doi: 10.1097/MOO.0000000000000876. Epub 2023 Feb 9. Curr Opin Otolaryngol Head Neck Surg. 2023. PMID: 36912227 Review.
PURPOSE OF REVIEW: A vagal paraganglioma is a rare head and neck tumor arising from the paraganglionic tissue within the perineurium of the vagus nerve, anywhere along the course of the nerve. Due to its proximity to the internal carotid artery, the internal jugular vein a …
PURPOSE OF REVIEW: A vagal paraganglioma is a rare head and neck tumor arising from the paraganglionic tissue within the perineurium of the …
Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H, Hutchens T, Baraban E, Schwartz LE, Montone K, Baloch Z, LiVolsi V, Krumeich L, Fraker DL, Nathanson KL, Cohen DL, Fishbein L. Wachtel H, et al. J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4661-70. doi: 10.1210/clinem/dgaa608. J Clin Endocrinol Metab. 2020. PMID: 32877928 Free PMC article.
PURPOSE: The Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) and the Grading System for Adrenal Pheochromocytoma and Paraganglioma (GAPP) are scoring systems to predict metastatic potential in pheochromocytomas (PCC) and paragangliomas (PGLs). The goal of this st …
PURPOSE: The Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) and the Grading System for Adrenal Pheochromocytoma and Paraganglioma …
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.
Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, Rakugi H, Ikeda Y, Tanabe A, Nigawara T, Ito S, Kimura I, Naruse M; Phaeochromocytoma Study Group in Japan. Kimura N, et al. Endocr Relat Cancer. 2014 May 6;21(3):405-14. doi: 10.1530/ERC-13-0494. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24521857
Although 10-30% of these tumours metastasise, histopathological criteria to discriminate malignant from benign tumours have not been established; therefore, reliable histopathological markers predicting metastasis are urgently required. A total of 163 tumours, including 40 …
Although 10-30% of these tumours metastasise, histopathological criteria to discriminate malignant from benign tumours have not been establi …
Rectal Paraganglioma.
Araki T, Takeshita S, Kawasaki H, Kusumoto K, Ohata K, Shigematsu K, Shigeno M. Araki T, et al. Intern Med. 2019 Jan 15;58(2):195-199. doi: 10.2169/internalmedicine.1218-18. Epub 2018 Aug 24. Intern Med. 2019. PMID: 30146582 Free PMC article. Review.
Since recurrence was confirmed three years later, reoperation was done, and chemotherapy with cyclophosphamide, vincristine and dacarbazine (CVD) was subsequently carried out for further recurrence. After the administration of up to 15 courses of CVD, we delivered best sup …
Since recurrence was confirmed three years later, reoperation was done, and chemotherapy with cyclophosphamide, vincristine and dacarbazine …
Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ. Gill AJ. Histopathology. 2018 Jan;72(1):106-116. doi: 10.1111/his.13277. Histopathology. 2018. PMID: 29239034 Review.
SDH-deficient gastrointestinal stromal tumours (GISTs) show distinctive features, including absent KIT proto-oncogene receptor tyrosine kinase/platelet-derived growth factor receptor A (KIT/PDGFRA) mutations [but positive staining for cKIT and DOG1], virtually exclusive gastric l …
SDH-deficient gastrointestinal stromal tumours (GISTs) show distinctive features, including absent KIT proto-oncogene receptor tyrosine kina …
The clinical genetics of phaeochromocytoma and paraganglioma.
Kavinga Gunawardane PT, Grossman A. Kavinga Gunawardane PT, et al. Arch Endocrinol Metab. 2017 Oct;61(5):490-500. doi: 10.1590/2359-3997000000299. Arch Endocrinol Metab. 2017. PMID: 29166454 Free PMC article. Review.
Early detection of a genetic mutation can lead to early diagnosis of further tumours via surveillance, early treatment and better prognosis. Apart from this, the genetic profile has important relevance for tumour location and biochemical profile, and can be a useful pre …
Early detection of a genetic mutation can lead to early diagnosis of further tumours via surveillance, early treatment and better prognos …
Malignant pheochromocytoma and paraganglioma: management options.
Corssmit EPM, Snel M, Kapiteijn E. Corssmit EPM, et al. Curr Opin Oncol. 2020 Jan;32(1):20-26. doi: 10.1097/CCO.0000000000000589. Curr Opin Oncol. 2020. PMID: 31599769 Review.
PURPOSE OF REVIEW: Although the majority of pheochromocytoma and paraganglioma are benign, 15-17% develop metastatic disease, being present at the initial diagnosis in about 11-31% of cases. The natural course of metastasized disease is highly heterogeneous, with an overal …
PURPOSE OF REVIEW: Although the majority of pheochromocytoma and paraganglioma are benign, 15-17% develop metastatic disease, being present …
1,246 results